NDC 51655-244
Valsartan 160 mg tablet, film coated
On the label: Northwind Pharmaceuticals. It's repackaged: Northwind Pharmaceuticals rebottles it from Mylan Pharmaceuticals Inc.'s NDC 0378-5814.
Where the pills inside were made
This label doesn't name the factory that makes the drug. Companies don't have to print it on the label. The maker's name is often on the stock bottle your pharmacy used; you can ask the pharmacist. See the plants Mylan Pharmaceuticals Inc. names for other drugs.
Repackaging site
- Northwind Health Company, LLC, Indianapolis, IN, United States · repackages it
Recalls
- Dec 4, 2018 · Class II · Mylan Laboratories Limited, (Nashik FDF)
GCMP Deviations: FDA analysis confirmed presence of trace amounts of an impurity, N-nitrosodiethylamine (NDEA) found in the API used to manufacture the product.
Lots: Lot Numbers: 3069019, 3069020, 3069021, 3069022, 3071354, 3071355, 3071357 3079023 3079027 3079028 3079029 3079996 3079997 3079998 3083635 3086715 3086716 3086717 3088623 - Nov 20, 2018 · Class II · Mylan Pharmaceuticals Inc.
CGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodiethylamine (NDEA) contained in the API used to manufacture the product.
Lots: Lot # 3071352, exp. date 7/2019
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Valsartan: every company that makes it
- Form
- tablet, film coated, oral
- Strength
- 160 mg
- Approval
- ANDA ANDA090866
- On the market since
- Oct 27, 2022
- Package NDCs
51655-244-52- Official label
- DailyMed (National Library of Medicine), updated Jan 1, 2026
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?